Blue Clay Health Welcomes Dr. Eneida O. Roldan to its Advisory Board

MIAMI - July 16, 2024 - PRLog -- MIAMI, FL – Blue Clay Health, a pioneering healthcare technology company, today announced the addition of Dr. Eneida O. Roldan, MD, MPH, MBA, to its distinguished Advisory Board. Dr. Roldan brings over 30 years of experience in the healthcare industry, further enhancing Blue Clay Health's mission to revolutionize care for patients with complex medical conditions.

Dr. Roldan joins an esteemed group of advisors, including leaders from renowned institutions such as Google Health, Medtronic, and the Dana-Farber Cancer Institute, and The March of Dimes. Her extensive background in healthcare management, education, and leadership will provide invaluable insights as Blue Clay Health continues to innovate and transform patient care.

"We are thrilled to welcome Dr. Eneida Roldan to our Advisory Board," said Chris Riley, Founder and CEO of Blue Clay Health. "Her wealth of experience in healthcare leadership, combined with her expertise in public health and healthcare systems, aligns perfectly with our mission to break down barriers and improve outcomes for patients with complex medical needs."

Dr. Roldan's impressive career includes serving as President and CEO of both public and private hospital systems, as well as roles in private practice, consulting, and as a principal investigator in healthcare organizations and pharmaceutical research. She is a professor in higher medical education institutions and a renowned national and international speaker on topics including obesity, healthcare management, health systems, and leadership.

"I am honored to join the Blue Clay Health Advisory Board and contribute to their groundbreaking work in healthcare technology," said Dr. Roldan. "The company's commitment to leveraging innovation to improve patient care aligns with my passion for advancing healthcare systems and education. I look forward to collaborating with the team to drive meaningful change in the industry."

Dr. Roldan's addition to the Advisory Board further strengthens Blue Clay Health's ability to address complex healthcare challenges and drive innovation in patient care. Her expertise in healthcare management and education will be instrumental as the company continues to develop and refine its Ensemble Care Hub platform.

For more information about Blue Clay Health and its Advisory Board, please visit http://www.blueclayhealth.com.

About Blue Clay Health

Blue Clay Health is a healthcare technology company dedicated to revolutionizing care for patients with complex medical conditions. By combining cutting-edge technology with a patient-centered approach, Blue Clay Health empowers patients, families, and healthcare providers to collaborate seamlessly and access the best possible care, regardless of location. The company's flagship o[ering, the Ensemble Care Hub, is a groundbreaking platform that leverages technology and advanced analytics to streamline care coordination, enable secure data sharing, and improve patient outcomes.

www.blueclayhealth.com

Contact:

media@blueclayhealth.com